Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Feb-23 10:00 PM View:  | Agios Pharmaceuticals, Inc. (AGIO) | 20-Sep-22 | Gift | 1,500 | -- | -- | (5%) 30.03K to 28.53K | |
| 24-May-22 4:10 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 20-May-22 | Option Exercise | 1,585 | -- | -- | 6% 28.44K to 30.03K | |
| 23-Dec-21 5:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Dec-21 | Payment of Exercise | 6,636 | $188.98 | $1,254,080.00 | (3%) 237.43K to 230.8K | |
| 23-Dec-21 5:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Dec-21 | Grant | 14,167 | -- | -- | 6% 223.26K to 237.43K | |
| 14-Dec-21 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Dec-21 | Option Exercise | 5,367 | $74.50 | $399,829.00 | 2% 217.9K to 223.26K | |
| 12-Nov-21 5:52 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Nov-21 | Option Exercise | 33,978 | $7.10 | $241,244.00 | 16% 217.9K to 251.88K | |
| 12-Nov-21 5:52 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Nov-21 | Market Option Sale (Planned) | 33,978 | $171.52 | $5,827,800.00 | (13%) 251.88K to 217.9K | |
| 02-Jun-21 4:09 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 28-May-21 | Option Exercise | 1,686 | -- | -- | 6% 26.76K to 28.44K | |
| 17-May-21 7:25 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-May-21 | Option Exercise | 33,979 | $7.10 | $241,251.00 | 16% 217.9K to 251.88K | |
| 17-May-21 7:25 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-May-21 | Market Option Sale (Planned) | 33,979 | $130.78 | $4,443,720.00 | (13%) 251.88K to 217.9K | |
| 21-Apr-21 6:20 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Apr-21 | Payment of Exercise | 7,507 | $131.85 | $989,822.00 | (3%) 225.41K to 217.9K | |
| 21-Apr-21 6:20 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Apr-21 | Grant | 16,236 | -- | -- | 8% 209.17K to 225.41K | |
| 26-Feb-21 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Feb-21 | Option Exercise | 33,979 | $7.10 | $241,251.00 | 16% 209.17K to 243.15K | |
| 26-Feb-21 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Feb-21 | Market Option Sale (Planned) | 33,979 | $147.31 | $5,005,420.00 | (14%) 243.15K to 209.17K | |
| 16-Feb-21 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Feb-21 | Payment of Exercise | 5,719 | $155.78 | $890,917.00 | (3%) 214.89K to 209.17K | |
| 16-Feb-21 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 11-Feb-21 | Grant | 14,166 | -- | -- | 7% 200.72K to 214.89K | |
| 02-Jun-21 4:09 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 04-Feb-21 | Gift | 3,415 | -- | -- | (11%) 30.17K to 26.76K | |
| 20-Nov-20 4:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Nov-20 | Option Exercise | 34,765 | $9.14 | $317,752.00 | 17% 200.72K to 235.49K | |
| 20-Nov-20 4:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Nov-20 | Market Option Sale (Planned) | 34,765 | $124.24 | $4,319,020.00 | (15%) 235.49K to 200.72K | |
| 21-Aug-20 4:06 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Aug-20 | Option Exercise | 34,765 | $9.14 | $317,752.00 | 17% 200.72K to 235.49K | |
| 21-Aug-20 4:06 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Aug-20 | Market Option Sale (Planned) | 34,765 | $136.13 | $4,732,540.00 | (15%) 235.49K to 200.72K | |
| 01-Jun-20 5:12 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 29-May-20 | Option Exercise | 1,878 | -- | -- | 7% 28.29K to 30.17K | |
| 22-May-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-May-20 | Option Exercise | 34,765 | $9.14 | $317,752.00 | 17% 200.72K to 235.49K | |
| 22-May-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-May-20 | Market Option Sale (Planned) | 34,765 | $143.22 | $4,978,980.00 | (15%) 235.49K to 200.72K | |
| 09-Apr-20 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Apr-20 | Grant | 14,167 | -- | -- | 7% 193.13K to 207.29K | |
| 09-Apr-20 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Apr-20 | Payment of Exercise | 6,571 | $104.81 | $688,701.00 | (3%) 207.29K to 200.72K | |
| 21-Feb-20 4:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Feb-20 | Option Exercise | 34,765 | $9.14 | $317,752.00 | 18% 193.13K to 227.89K | |
| 21-Feb-20 4:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Feb-20 | Market Option Sale (Planned) | 34,765 | $131.85 | $4,583,670.00 | (15%) 227.89K to 193.13K | |
| 28-Feb-20 4:18 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 14-Feb-20 | Gift | 4,315 | -- | -- | (13%) 32.61K to 28.29K | |
| 16-Oct-19 4:06 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 14-Oct-19 | Option Exercise | 49,456 | $16.43 | $812,562.00 | 26% 193.13K to 242.58K | |
| 16-Oct-19 4:06 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 14-Oct-19 | Market Option Sale (Planned) | 49,456 | $79.45 | $3,929,210.00 | (20%) 242.58K to 193.13K | |
| 07-Aug-19 4:16 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 11-Jul-19 | Acquisition (other) | 34 | -- | -- | < 1% 193.09K to 193.13K | |
| 14-Jun-19 4:20 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 12-Jun-19 | Gift | 5,000 | -- | -- | (13%) 37.61K to 32.61K | |
| 31-May-19 4:08 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 31-May-19 | Option Exercise | 1,400 | -- | -- | 4% 36.21K to 37.61K | |
| 17-May-19 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 15-May-19 | Option Exercise | 49,457 | $16.43 | $812,578.00 | 26% 193.09K to 242.55K | |
| 17-May-19 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 15-May-19 | Market Option Sale (Planned) | 49,457 | $70.00 | $3,461,990.00 | (20%) 242.55K to 193.09K | |
| 17-May-19 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Apr-19 | Acquisition (other) | 61 | -- | -- | < 1% 193.03K to 193.09K | |
| 26-Nov-18 4:11 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Nov-18 | Payment of Exercise | 59,940 | $72.68 | $4,356,440.00 | (24%) 252.97K to 193.03K | (15%) |
| 26-Nov-18 4:11 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Nov-18 | Option Exercise | 98,636 | $21.35 | $2,105,880.00 | 64% 154.34K to 252.97K | |
| 26-Nov-18 4:11 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Oct-18 | Acquisition (other) | 17 | -- | -- | < 1% 154.32K to 154.34K | |
| 13-Sep-18 4:01 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 12-Sep-18 | Market Sale | 14,162 | $71.74 | $1,015,980.00 | (39%) 36.21K to 22.05K | 42% |
| 13-Sep-18 4:01 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 11-Sep-18 | Market Sale | 13,555 | $72.75 | $986,128.00 | (27%) 49.76K to 36.21K | 42% |
| 27-Jul-18 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Jul-18 | Option Exercise | 50,000 | $21.35 | $1,067,500.00 | 32% 154.32K to 204.32K | |
| 27-Jul-18 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Jul-18 | Market Option Sale (Planned) | 50,000 | $105.39 | $5,269,460.00 | (24%) 204.32K to 154.32K | 21% |
| 27-Jul-18 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Jul-18 | Acquisition (other) | 31 | -- | -- | < 1% 154.29K to 154.32K | |
| 27-Jul-18 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Apr-18 | Acquisition (other) | 30 | -- | -- | < 1% 154.26K to 154.29K | |
| 21-Dec-17 4:36 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Dec-17 | Option Exercise | 1,587 | $63.00 | $99,981.00 | 1% 152.67K to 154.26K | |
| 24-Nov-17 6:55 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Nov-17 | Option Exercise | 73,415 | $31.39 | $2,304,500.00 | 48% 152.67K to 226.09K | |
| 24-Nov-17 6:55 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Nov-17 | Market Option Sale (Planned) | 73,415 | $130.90 | $9,609,740.00 | (32%) 226.09K to 152.67K | 36% |
| 17-Nov-17 5:35 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Nov-17 | Option Exercise | 74,000 | $31.39 | $2,322,860.00 | 48% 152.67K to 226.67K |